University of Erlangen-Nürnberg Medical School: Hypertension trials
The registry lists 13 Hypertension studies with University of Erlangen-Nürnberg Medical School as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 7No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- OCTA in Cardiovascular Disease and Healthy ControlsRecruitingNCT07359664Not applicable
- WB-EMS Effects on Cardiometabolic Risk FactorsActive, not recruitingNCT07406191Not applicable
- Genetic Based Analysis in Hypertensive PatientsCompletedNCT04321044Not applicable
- The Influence of Aircraft Noise Exposure on Renal Hemodynamic in Healthy IndividualsCompletedNCT02783456Not applicable
- Renal Denervation in Treatment Resistant HypertensionCompletedNCT01687725
- Aliskiren on Retinal Vasculature Treatment StudyCompletedNCT01318395Phase 3
- Importance of Aldosterone in the Pathogenesis of Hypertensive Heart DiseaseCompletedNCT00865501Phase 3
- A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive PatientsCompletedNCT00627952Phase 3
- Sympathetic Overactivity in Essential HypertensionWithdrawnNCT00541619
- Effect of Pioglitazone on Ambulatory Blood PressureCompletedNCT00328393Phase 3
- Effect of Losartan on Retinal Endothelial Function in Patients With Essential HypertensionWithdrawnNCT00152633Phase 2/3
- Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial HypertensionCompletedNCT00138944Phase 3
- L-Arginine Metabolism in Essential HypertensionCompletedNCT00137124Phase 2/3